Prokinetic agents in critical care

Critical Care

Volumn 7, Issue 3, 2003, Pages 206-208

  Doherty, Warren L ^a   Winter, Bob ^a  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMCINAL; CISAPRIDE; ERYTHROMYCIN; GLUCOSE; MACROLIDE; METOCLOPRAMIDE; PLACEBO; PROKINETIC AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; ARTIFICIAL VENTILATION; ASPIRATION PNEUMONIA; CLINICAL PRACTICE; CLINICAL STUDY; DRUG EFFICACY; ENTERIC FEEDING; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL MOTILITY; HUMAN; HYPERGLYCEMIA; INTENSIVE CARE; INTESTINE TRANSIT TIME; MEDICAL LITERATURE; METHODOLOGY; PRIORITY JOURNAL; STOMACH FUNCTION; STOMACH VOLUME; TREATMENT OUTCOME;

CISAPRIDE; CRITICAL CARE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENTERAL NUTRITION; ERYTHROMYCIN; GASTROINTESTINAL AGENTS; GASTROINTESTINAL MOTILITY; HUMANS; METOCLOPRAMIDE; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); RESEARCH DESIGN; TREATMENT OUTCOME;

EID: 0037972384     PISSN: 13648535     EISSN: None     Source Type: Journal    
DOI: 10.1186/cc1849     Document Type: Article

References (23)

1. Miskovitz P: Gastric prokinetic motility therapy to facilitate early enteral nutrition in the intensive care unit. Crit Care Med 2002, 30:1386-1387.
2. Marik PE, Zaloga GP: Early enteral nutrition in acutely ill patients: A systematic review. Crit Care Med 2001, 29:2264-2270.
3. Zaloga GP: Early enteral nutritional support improves outcome: hypothesis or fact? Crit Care Med 1999, 27:259-261.
4. Heyland DK, Cook DJ, Guyatt GH: Enteral nutrition in the critically ill patient: a critical review of the evidence. Intensive Care Med 1993, 19:435-442.
5. Hadfield RJ, Sinclair DJ, Houldsworth PE, Evans TW: Effects of enteral and parenteral nutrition on gut mucosal permeability in the critically ill. Am J Respir Crit Care Med 1995, 152:1545-1548.
6. Saito H, Trocki O, Alexander JW, Kopcha R, Heyd T, Joffe SN: The effect of route of nutrient administration on the nutritional state, catabolic hormone secretion, and gut mucosal integrity after burn injury. JPEN J Parenter Enteral Nutr 1987, 11:1-7.
7. Kudsk KA, Minard G, Wojtysiak SL, Croce M, Fabian T, Brown RO: Visceral protein response to enteral versus parenteral nutrition and sepsis in patients with trauma. Surgery 1994, 116:516-523.
8. Moore FA, Feliciano DV, Andrassy RJ, McArdle AH, Booth FV, Morgenstein-Wagner TB, Kellum JM Jr, Welling RE, Moore EE: Early enteral feeding, compared with parenteral, reduces postoperative septic complications: the results of a meta-analysis. Ann Surg 1992, 216:172-183.
9. Booth CM, Heyland DK, Paterson WG: Gastrointestinal promotility drugs in the critical care setting: a systematic review of the evidence. Crit Care Med 2002, 30:1429-1435.
10. Tisherman SA, Marik PE, Ochoa J: Promoting enteral feeding 101. Crit Care Med 2002, 30:1653-1654.
11. Wysowski DK, Bacsanyi J: Cisapride and fatal arrhythmia. N Engl J Med 1996, 335:290-291.
12. Tack J. Peeters T: What comes after macrolides and other motilin stimulants? Gut 2001, 49:317-318.
13. Talley NJ, Verlinden M, Geenen DJ, Hogan RB, Riff D, McCallum RW, Mack RJ: Effects of a motilin receptor agonist (ABT-229) on upper gastrointestinal symptoms in type 1 diabetes mellitus: a randomised, double blind, placebo controlled trial. Gut 2001, 49:395-401.
14. Whatley K, Turner WW Jr, Dey M, Leonard J, Guthrie M: When does metoclopramide facilitate transpyloric intubation? JPEN J Parenter Enteral Nutr 1984, 8:679-681.
15. Jooste CA, Mustoe J, Collee G: Metoclopramide improves gastric motility in critically ill patients. Intensive Care Med 1999, 25:464-468.
16. Jones KL, Kong MF, Berry MK, Rayner CK, Adamson U, Horowitz M: The effect of erythromycin on gastric emptying is modified by physiological changes in the blood glucose concentration. Am J Gastroenterol 1999, 94:2074-2079.
17. Kong MF. Horowitz M: Gastric emptying in diabetes mellitus: relationship to blood-glucose control. Clin Geriatr Med 1999, 15:321-338.
18. Jones KL, Berry M, Kong MF, Kwiatek MA, Samsom M, Horowitz M: Hyperglycemia attenuates the gastrokinetic effect of erythromycin and affects the perception of postprandial hunger in normal subjects. Diabetes Care 1999, 22:339-344.
19. Reignier J, Bensaid S, Perrin-Gachadoat D, Burdin M, Boiteau R, Tenaillon A: Erythromycin and early enteral nutrition in mechanically ventilated patients. Crit Care Med 2002, 30: 1237-1241.
20. Chapman MJ, Fraser RJ, Kluger MT, Buist MD, De Nichilo DJ: Erythromycin improves gastric emptying in critically ill patients intolerant of nasogastric feeding. Crit Care Med 2000, 28: 2334-2337.
21. Coulie B, Tack J, Peeters T, Janssens J: Involvement of two different pathways in the motor effects of erythromycin on the gastric antrum in humans. Gut 1998, 43:395-400.
22. Tack J, Janssens J, Vantrappen G, Peeters T, Annese V, Depoortere I, Muls E, Bouillon R: Effect of erythromycin on gastric motility in controls and in diabetic gastroparesis. Gastroenterology 1992, 103:72-79.
23. Feighner SD, Tan CP, McKee KK, Palyha OC, Hreniuk DL, Pong SS, Austin CP, Figueroa D, MacNeil D, Cascieri MA, Nargund R, Bakshi R, Abramovitz M, Stocco R, Kargman S, O'Neill G, Van Der Ploeg LH, Evans J, Patchett AA, Smith RG, Howard AD: Receptor for motilin identified in the human gastrointestinal system. Science 1999, 284:2184-2188.